Patent 7288567 was granted and assigned to Methylgene Inc. on October, 2007 by the United States Patent and Trademark Office.
The invention relates to the inhibition of histone deacetylase. The invention provides compounds and methods for inhibiting histone deacetylase enzymatic activity. The invention also provides compositions and methods for treating cell proliferative diseases and conditions.